Elo Mutual Pension Insurance Co Makes New $1.03 Million Investment in HealthEquity, Inc. $HQY

Elo Mutual Pension Insurance Co acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,884 shares of the company’s stock, valued at approximately $1,031,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Sivia Capital Partners LLC bought a new stake in HealthEquity in the 2nd quarter valued at $306,000. Envestnet Asset Management Inc. boosted its position in shares of HealthEquity by 5.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 136,259 shares of the company’s stock valued at $14,187,000 after acquiring an additional 7,602 shares in the last quarter. Huntington National Bank boosted its position in shares of HealthEquity by 119.3% during the 2nd quarter. Huntington National Bank now owns 750 shares of the company’s stock valued at $79,000 after acquiring an additional 408 shares in the last quarter. Fox Run Management L.L.C. bought a new stake in HealthEquity in the second quarter valued at about $915,000. Finally, Campbell & CO Investment Adviser LLC raised its position in HealthEquity by 329.0% in the second quarter. Campbell & CO Investment Adviser LLC now owns 16,918 shares of the company’s stock worth $1,772,000 after purchasing an additional 12,974 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. upped their price objective on HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. Barclays cut their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. BMO Capital Markets set a $85.00 target price on shares of HealthEquity in a research note on Tuesday, February 24th. Finally, Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $112.00.

Insider Transactions at HealthEquity

In other news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.50% of the company’s stock.

HealthEquity Price Performance

Shares of HQY stock opened at $79.96 on Friday. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $116.65. The stock has a market capitalization of $6.83 billion, a PE ratio of 36.68, a PEG ratio of 1.01 and a beta of 0.26. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The stock’s fifty day moving average is $83.57 and its 200-day moving average is $90.85.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. During the same period in the previous year, the business posted $0.78 earnings per share. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.